131256-74-1

Basic information

• Product Name: (TYR(ME)21)-NEUROPEPTIDE Y (HUMAN, RAT)
• Synonyms: H-TYR-PRO-SER-LYS-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ALA-PRO-ALA-GLU-ASP-MET-ALA-ARG-TYR-TYR(ME)-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR-NH2;H-TYR-PRO-SER-LYS-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ALA-PRO-ALA-GLU-ASP-MET-ALA-ARG-TYR-TYR(OME)-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR-NH2;[O-METHYL-TYR21]-NEUROPEPTIDE Y HUMAN;[TYR(OME)21]-NEUROPEPTIDE Y, HUMAN;[TYR(OME)21] NPY, HUMAN;(TYR(ME)21)-NEUROPEPTIDE Y (HUMAN, RAT);(TYR(ME)21)-NPY (HUMAN, RAT);YPSKPDNPGEDAPAEDMARYY(OME)SALRHYINLITRQRY-NH2
• CAS NO: 131256-74-1
• Molecular Formula: C190H287N55O57S1
• Molecular Weight: 4285.71
• Product Categories: peptide
• Mol File: 131256-74-1.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: −20°C
• CAS DataBase Reference: (TYR(ME)21)-NEUROPEPTIDE Y (HUMAN, RAT)(CAS DataBase Reference)
• NIST Chemistry Reference: (TYR(ME)21)-NEUROPEPTIDE Y (HUMAN, RAT)(131256-74-1)
• EPA Substance Registry System: (TYR(ME)21)-NEUROPEPTIDE Y (HUMAN, RAT)(131256-74-1)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 131256-74-1(Hazardous Substances Data)

Usage

Description

(TYR(ME)21)-NEUROPEPTIDE Y (HUMAN, RAT) is a modified form of the neuropeptide Y, a 36-amino acid peptide neurotransmitter that plays a crucial role in the regulation of appetite, energy balance, and stress response. The modification of tyrosine at position 21 with a methyl group enhances the stability and potency of the peptide, making it a promising candidate for therapeutic applications. This modified neuropeptide Y has been studied for its potential to modulate feeding behavior, energy expenditure, and cardiovascular function, and may have implications for the treatment of obesity, metabolic disorders, and cardiovascular diseases. Further research is needed to fully understand the pharmacological properties and therapeutic potential of (TYR(ME)21)-NEUROPEPTIDE Y (HUMAN, RAT).

Uses

Used in Pharmaceutical Industry:
(TYR(ME)21)-NEUROPEPTIDE Y (HUMAN, RAT) is used as a therapeutic agent for the treatment of obesity and metabolic disorders due to its potential to modulate feeding behavior and energy expenditure. The increased stability and potency of the modified peptide may provide a more effective approach to managing these conditions.
Used in Cardiovascular Research:
(TYR(ME)21)-NEUROPEPTIDE Y (HUMAN, RAT) is used as a research tool in cardiovascular studies to investigate its potential impact on cardiovascular function. The peptide's role in modulating stress response and energy balance may offer insights into the development of new treatments for cardiovascular diseases.
Used in Neuroscience Research:
(TYR(ME)21)-NEUROPEPTIDE Y (HUMAN, RAT) is used as a research tool in neuroscience to study the mechanisms underlying appetite regulation, energy balance, and stress response. Understanding the pharmacological properties of this modified neuropeptide Y may contribute to the development of novel therapeutic strategies for neurological disorders and conditions related to stress and energy homeostasis.